Smart multifunctional GLA-nanoformulation for Fabry disease

Informacje na temat projektu

Smart-4-Fabry

Identyfikator umowy o grant: 720942

DOI 10.3030/720942

Projekt został zamknięty

Data podpisania przez KE 22 Listopada 2016

Data rozpoczęcia 1 Stycznia 2017

Data zakończenia 31 Grudnia 2020

Finansowanie w ramach

• INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Nanotechnologies

Koszt całkowity € 5 844 508,63

Wkład UE € 5 844 508,63

Koordynowany przez

CONSORCIO CENTRO DE INVESTIGACION BIOMEDICA EN RED M.P.
Spain

Rezultaty

Documents, reports (4)

Linkedin, Youtube, Twitter

Feeding and reporting activities of the social communities

Press and social media repercussion

Report on press appearances and social media repercussion

Use and dissemination Plan

Report defining the activities related to the use and dissemination of the project's results

Compilation of scientific papers published

Report with a Compilation of the scientific papers published during the project

Other (2)

Smart-4-Fabry Final Expo
Project/group presentations

Group presentation/special seminar at appropriate pharmaceutical conference

Websites, patent fillings, videos etc. (1)

Smart-4-Fabry public website

Development and follow-up of a website with the information/activities of the project

Publikacje

Peer reviewed articles (2)

Synthesis of Stable Cholesteryl–Polyethylene Glycol–Peptide Conjugates with Non-Disperse Polyethylene Glycol Lengths

Autorzy: Edgar Cristóbal-Lecina, Daniel Pulido, Pau Martin-Malpartida, Maria J. Macias, Fernando Albericio, Miriam Royo
Opublikowane w: ACS Omega, Numer 5/10, 2020, Strona(/y) 5508-5519, ISSN 2470-1343
Wydawca: ACS Publications
DOI: 10.1021/acsomega.0c00130

Impact of Chemical Composition on the Nanostructure and Biological Activity of α-Galactosidase-Loaded Nanovesicles for Fabry Disease Treatment

Autorzy: Judit Tomsen-Melero, Solène Passemard, Natalia García-Aranda, Zamira Vanessa Díaz-Riascos, Ramon González-Rioja, Jannik Nedergaard Pedersen, Jeppe Lyngsø, Josep Merlo-Mas, Edgar Cristóbal-Lecina, José Luis Corchero, Daniel Pulido, Patricia Cámara-Sánchez, Irina Portnaya, Inbal Ionita, Simó Schwartz, Jaume Veciana, Santi Sala, Miriam Royo, Alba Córdoba, Dganit Danino, Jan Skov Pedersen,
Opublikowane w: ACS Applied Materials & Interfaces, 2021, ISSN 1944-8244
Wydawca: American Chemical Society
DOI: 10.1021/acsami.0c16871

Prawa własności intelektualnej

Patent (3)

ES: “LIPOSOMAS FUNCIONALIZADOS ÚTILES PARA LA LIBERACIÓN DE COMPUESTOS BIOACTIVOS”.INT: “FUNCTIONALIZED LIPOSOMES USEFUL FOR THE DELIVERY OF BIOACTIVE COMPOUNDS”

Numer wniosku/publikacji: ES P201231020
Data: 2012-06-29

ES: “LIPOSOMAS FUNCIONALIZADOS ÚTILES PARA LA LIBERACIÓN DE COMPUESTOS BIOACTIVOS”.INT: “FUNCTIONALIZED LIPOSOMES USEFUL FOR THE DELIVERY OF BIOACTIVE COMPOUNDS”

Numer wniosku/publikacji: ES P201231020
Data: 2012-06-29

ES: “LIPOSOMAS FUNCIONALIZADOS ÚTILES PARA LA LIBERACIÓN DE COMPUESTOS BIOACTIVOS”.INT: “FUNCTIONALIZED LIPOSOMES USEFUL FOR THE DELIVERY OF BIOACTIVE COMPOUNDS”

Numer wniosku/publikacji: ES P201231020
Data: 2012-06-29
Wnioskodawca/wnioskodawcy: FUNDACIO PARC CIENTIFIC DE BARCELONA